Navigation Links
ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx
Date:9/19/2007

WINDSOR, Ontario, Sept. 19 /PRNewswire/ -- ArtJen Complexus Holdings Corp. (http://www.fbcx.com) today announced that, following the results of their clinical trial with obese type 2 diabetics and an animal study at the National Institutes of Health, FBCx is being studied by a major US west-coast university medical center. The largest study to date on the patented all- natural soluble fiber that binds dietary fat will involve overweight but not obese individuals.

"Our earlier study with obese, type 2 diabetics demonstrated significant weight loss when adjusted for changes in diet." said FBCx co-inventor, Dr. Catherine Jen. "It's time to look at the non-obese population segment that would benefit from losing 10-25 pounds."

"We expect this study will show FBCx to be an easy and effective aid for losing weight and for lowering elevated levels of blood fats," continued FBCx co-inventor, Dr. Joseph Artiss.

Previous FBCx study findings include:

-- Effective at reducing and/or maintaining body weight in patients with

type 2 diabetes.

-- Lowered both triglyceride and LDL (bad) cholesterol levels in patients

who began the study with elevated triglyceride levels.

-- Blood work findings indicate an insulin sensitivity increase and

therefore a possible delay in the need to institute or the intensity of

insulin therapy in type 2 diabetics.

-- FBCx was shown to bind and remove 9 times its own weight in dietary

fat, essentially preventing 80 calories from being absorbed per tablet.

-- FBCx appears to preferentially bind saturated over unsaturated dietary

fats.

-- FBCx produced no adverse side effects.

These findings and others have lead to FBCx being referred to as the "miracle weight loss" pill in media reports and by renowned members of the medical profession.

"We are so convinced of the efficacy of FBCx that we sought out and funded this major study ourselves," said Dr. Artiss.

"I have spent my entire career studying obesity. FBCx works where most others have failed to live up to their hype," stated Dr. Jen.

FBCx co-inventors are Associate Professor of Pathology Joseph Artiss, Ph.D., FACB and K-L Catherine Jen, Ph.D., Professor and Chair of Nutrition and Food Science, both of Wayne State University in Detroit, Michigan.

Six tablets daily are capable of removing 50-60% of the calories from a typical North American diet.


'/>"/>
SOURCE ArtJen Complexus Holdings Corp.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... New York , January 24, 2017 ... three players held a whopping share of 91.6% in ... Technology, IMA Pharma, and Qualipcaps have been leading the ... leaders boast an experience and expertise in handling sophisticated ... companies are expected to focus on research and development ...
(Date:1/24/2017)... , Jan. 24, 2017   QR ... biopharmaceutical company developing novel therapies for the treatment ... announced the appointment of four world-class key opinion ... new appointments join QR Pharma,s previous roster of ... and direction to support the development of the ...
(Date:1/24/2017)... January 24, 2017 The global  ... USD 3.8 billion by 2025, according to a new ... can be attributed to the rising initiatives by various ... of micro calcifications in breast tissue. Some significant organizations ... Breast Cancer Organization are promoting the early diagnosis of ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... 2017 , ... Learn to use popular brainwave and heart rhythm equipment to ... offered by Dr. Carol Francis at PVNET on Sundays in February and March and ... experiences. , Dr. Carol Francis shows business owners, parents, athletes, students and ...
(Date:1/24/2017)... ... , ... His message has been heard by more than 100,000 students and ... , Joel Feldman, has reached his biggest national audience yet: the three million daily ... newspapers in circulation in the country, and he hopes it will help spread his ...
(Date:1/24/2017)... ... , ... The University of Iowa, long recognized as one of the top ... provides teachers with the specific skills and training they need to teach English as ... students and HigherEducation.com is working to ensure that this new program is available to ...
(Date:1/24/2017)... ... ... American Family Care (AFC) has opened a new 4,000+ square foot state-of-the-art urgent ... area. The Bedford clinic will be the nineteenth location opened by AFC in Massachusetts ... Dr. Kristina Orio. Adams and Orio also independently own and operate AFC clinics in ...
(Date:1/24/2017)... ... January 24, 2017 , ... “Choosing Wisdom-Solomon’s ... finances, friendship, marriage, leadership, gossip, prostitution, adultery, anger, and common sense. , ... Judith Coats and Dr. David Coats. In September of 1983, they flew to ...
Breaking Medicine News(10 mins):